Analystreport

PTC Therapeutics, Inc. (NASDAQ: PTCT) was downgraded by analysts at ValuEngine from a "strong-buy" rating to a "buy" rating.

PTC Therapeutics, Inc.  (PTCT) 
Last ptc therapeutics, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.ptcbio.com